Kid stuff the focus for new theater

February 29, 2008
Back to TopCommentsE-mailPrintBookmark and Share
In yesterday’s IBJ Daily A&E e-mail, I discussed the Children’s Theatre Institute at the Junior Achievement Center, which officially opens its doors tonight with a party and performance of “Treasure Island.” The company promises a full slate of kid-centric productions, including collaborations with the Indianapolis Symphony Orchestra.

At the helm of this particular creative ship is James Leagre (who I misidentified in my e-mail as being in the IRT’s “Our Town.” He wasn’t. Sorry). Leagre is a seasoned actor who not only has appeared in such grown-up productions as The Beckman Theatre’s “Asylum” and “The Guys” at the Wheeler Arts Center, but has also demonstrated a long commitment to creating productions for young audiences. He’s also a 2008 Indiana Arts Commission Creative Renewal Fellow, which indicates that his talents aren’t going unnoticed.

Having a professional full-time children’s theater in town isn’t kid stuff. It’s one more step toward Indy being the well-rounded arts community that it can be. In my view, quality children’s theater is as important as quality opera, quality dance and, for that matter, quality pizza.

That isn’t to say that there aren’t other producers of children’s theater in town. But to have a place dedicated to quality children’s theater is significant. Here’s hoping it lives up to its promise.

See you at the opening tonight.
  • Hooray for CTI! They not only have a great commitment to Indy's youth, but are wonderful people to work with. It is no small thing that they provide local actors with paying work! Indianapolis JA should also be appluaded for providing CTI with a home. Both are worthy of Indianapolis' support.

Post a comment to this blog

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
  1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

  2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

  3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

  4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

  5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?